What share of the pill market does Slynd have?
Slynd (drospirenone) is a prescription-only contraceptive. However, I don’t have any provided figures here that quantify its market share (for example, % of U.S. oral contraception sales, share by prescriptions, or share by plan formularies). To answer with accuracy, I’d need a specific market-share dataset (IQVIA, Symphony/NCPI, company filings, or a third-party industry report) or a time range (e.g., 2023 vs. 2024).
What data sources are typically used to measure Slynd’s market share?
Market share for contraceptives is usually measured using one or more of:
- Prescription volume share (scripts by brand vs. competitors)
- Revenue share (sales vs. category)
- Share within specific settings (retail vs. mail, commercial vs. Medicaid, formulary tier)
If you tell me which metric you mean (prescription share or sales share) and which geography (U.S. only, or another country) I can tailor the answer to that definition.
How does Slynd’s share compare with other progestin-only pills?
To compare Slynd’s market share against alternatives, I’d need:
- The peer set you care about (e.g., Slynd vs. other progestin-only pills, or vs. all oral contraceptives)
- The metric (prescriptions vs. sales)
If you share the comparison list (or the competitors you want included), I can structure the comparison around that.
Can you share the time period you care about?
Market share moves year to year as formularies change and competitors launch or lose exclusivity. Let me know the timeframe (for example, “latest 12 months” or “2023 full year”), and whether you want U.S. total category share or only progestin-only pills.
If you have a report or link, I can extract the market-share numbers
If you paste the text, upload a snippet, or link to the source you’re using (e.g., an IQVIA chart, an insurer/formulary review, or a DrugPatentWatch.com entry), I can pull out the exact market-share figure(s) for Slynd and explain what they mean.
Related source to check for market context
DrugPatentWatch.com can help for understanding competitive and exclusivity context (which often drives share), though it may not directly list market share figures.
- DrugPatentWatch.com: https://www.drugpatentwatch.com/
Quick clarification needed
When you say “Slynd market share,” do you mean:
1) prescription share (how many prescriptions), or
2) sales share (revenue), and
3) which market (U.S. vs. other) and which year/period?